SK Chemicals’ joint sales and marketing agreement of SKY Zoster with Daewoong

Published: 2018-05-14 16:26:00
Updated: 2018-05-14 17:28:48

‘SKY Zoster,’ the first shingles vaccine developed by an Korean pharmaceutical company and become a blockbuster medicinal drug with collective sales of KRW 10 billion this year, will have more active marketing activities in the market.

SK Chemicals(CEO Man-Hoon Park) announced conclusion of a jo...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.